TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88397912

Filing Date: 04/23/2019

To the Commissioner for Trademarks:

MARK: DRUGOME (Standard Characters, see below )

The literal element of the mark consists of DRUGOME.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Roivant Sciences GmbH, a gesellschaft mit beschränkter haftung (gmbh) legally organized under the laws of Switzerland, having an address of
      Viaduktstrasse 8
      Basel 4051
      Switzerland

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 009:  Computer software; computer software for providing, analyzing and generating reports; computer software for data processing; software, programs and systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; software, programs and systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research, and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Switzerland application number 80616/2018, filed 10/24/2018.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of Switzerland registration number 728943, and/or proof of renewal, registered 03/27/2019 with a renewal date of __________ and an expiration date of 10/24/2028, and translation thereof, if appropriate.

Original PDF file:
reg-20671224226-115717730_._Swiss_registration_certificate_for_DRUGOME__F3011118x96B9E_.pdf
Converted PDF file(s) (8 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Foreign Registration-4
Foreign Registration-5
Foreign Registration-6
Foreign Registration-7
Foreign Registration-8

The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character equivalent.

       International Class 035:  Advertising; business management; business administration; office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; artificial intelligence and machine learning statistical analysis, consultancy and reporting for pharmaceutical and biomedical research; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data; systematization and compilation of data in computer databases, in particular compilation of information into computer databases for research and analysis purposes in the field of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business analysis and consultancy and statistical analysis in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Switzerland application number 80616/2018, filed 10/24/2018.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of Switzerland registration number 728943, and/or proof of renewal, registered 03/27/2019 with a renewal date of __________ and an expiration date of 10/24/2028, and translation thereof, if appropriate.

Original PDF file:
reg-1-20671224226-115717730_._Swiss_registration_certificate_for_DRUGOME__F3011118x96B9E_.pdf
Converted PDF file(s) (8 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Foreign Registration-4
Foreign Registration-5
Foreign Registration-6
Foreign Registration-7
Foreign Registration-8

The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character equivalent.

       International Class 036:  Financial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, compiling and analyzing statistics and data; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and clinical and post-market trials

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Switzerland application number 80616/2018, filed 10/24/2018.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of Switzerland registration number 728943, and/or proof of renewal, registered 03/27/2019 with a renewal date of __________ and an expiration date of 10/24/2028, and translation thereof, if appropriate.

Original PDF file:
reg-2-20671224226-115717730_._Swiss_registration_certificate_for_DRUGOME__F3011118x96B9E_.pdf
Converted PDF file(s) (8 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Foreign Registration-4
Foreign Registration-5
Foreign Registration-6
Foreign Registration-7
Foreign Registration-8

The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character equivalent.

       International Class 042:  Scientific and technological services and research and design relating thereto; analysis of technical data by computers; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Switzerland application number 80616/2018, filed 10/24/2018.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.

Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of Switzerland registration number 728943, and/or proof of renewal, registered 03/27/2019 with a renewal date of __________ and an expiration date of 10/24/2028, and translation thereof, if appropriate.

Original PDF file:
reg-3-20671224226-115717730_._Swiss_registration_certificate_for_DRUGOME__F3011118x96B9E_.pdf
Converted PDF file(s) (8 pages)
Foreign Registration-1
Foreign Registration-2
Foreign Registration-3
Foreign Registration-4
Foreign Registration-5
Foreign Registration-6
Foreign Registration-7
Foreign Registration-8

The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character equivalent.


The applicant's current Attorney Information:
      Allison Strickland Ricketts and Joyce M. Ferraro of Fross Zelnick Lehrman & Zissu, P.C.      4 Times Square, 17th Floor
      New York, New York 10036
      United States
      212-813-5900(phone)
      ricketts-docket@fzlz.com (authorized)
The attorney docket/reference number is ROIV 1905651.

The applicant's current Correspondence Information:

Allison Strickland Ricketts

Fross Zelnick Lehrman & Zissu, P.C.

4 Times Square, 17th Floor

New York, New York 10036

212-813-5900(phone)

ricketts-docket@fzlz.com;ferraro-docket@fzlz.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $1100 has been submitted with the application, representing payment for 4 class(es).

Declaration

Declaration Signature
The attached signature image file:
\\TICRS\EXPORT17\IMAGEOUT17\883\979\88397912\xml1\RFA0035.JPG



Signatory's Name: Sascha Bucher
Signatory's Position: VP, Head of Global Transactions
Payment Sale Number: 88397912
Payment Accounting Date: 04/24/2019

Serial Number: 88397912
Internet Transmission Date: Tue Apr 23 12:09:36 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-201904231209361
69943-88397912-620e19d85ead04ea7f773cd4a
39589c0d8e83bf12ca3277b4d75a2db66f2e29e7
-DA-1473-20190423120654522339